A significant increase (P0.05) in renal MDA content (650.86%) and decreases (P0.05) in renal GSH, SOD, CAT and TAC were recorded (67.63%, 83.23%, 86.96%, 64% and 79.1%, respectively) compared with the control group
In a recent study published in Nature, researchers developed the MK-801 bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models of metabolic illness by combining N-methyl-D-aspartate (NMDA) receptor antagonism with glucagon-like peptide-1 (GLP-1) receptor antagonism
Brands that reimagine formats, packaging, and messaging to be appetite-aware will not only mitigate headwinds
HS: A Logical (If Earlier) Target Hidradenitis suppurativa is closely linked to obesity, metabolic dysfunction, and smoking